Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 3/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.60 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.60 |
| ▸ | UGT1A9 | O60656 | 1/20 | 0.60 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.60 |
| ▸ | ALB | P02768 | 1/20 | 0.60 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.60 |
| ▸ | UGT1A6 | P19224 | 1/20 | 0.60 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.60 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25720672 | 0.89 | TTR (0.60) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL25718991 | 0.88 | TTR (0.68) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL6431084 | 0.88 | TTR (0.71) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL10844751 | 0.86 | TTR (0.70) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL13299162 | 0.86 | TTR (0.73) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL23158669 | 0.86 | TTR (0.65) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL26655544 | 0.86 | TTR (0.80) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL13109329 | 0.85 | TTR (0.68) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL17001514 | 0.85 | TTR (0.71) | TTRCYP2C9USP2LMNATBXA2R | |
| SCHEMBL13922743 | 0.85 | TTR (0.74) | TTRCYP2C9USP2LMNATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190943-A1 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| WO-2021060351-A1 | NSAID-BONDED ALGINIC ACID DERIVATIVE | 持田製薬株式会社 | 2021-04-01 | — | — | WO | disclosed |
| WO-2019182015-A1 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | 持田製薬株式会社 | 2019-09-26 | — | — | WO | disclosed |
| US-9403793-B2 | Compositions and methods for the treatment of moderate to severe pain | CELLIX BIO PRIVATE LIMITED (IN) | 2016-08-02 | — | — | US | disclosed |
| US-20150353522-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2015-12-10 | — | — | US | disclosed |
| US-9108942-B1 | Compositions and methods for the treatment of moderate to severe pain | KANDULA MAHESH (IN) | 2015-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353522-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MODERATE TO SEVERE PAIN | TNNC1, GYS1, SCN3A | TTR 244/4885CYP2C9 280/4885USP2 4560/4885 |
| US-20230190943-A1 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | ALG1, ALG8, ALG3 | TTR 4779/4885CYP2C9 3313/4885USP2 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.